This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnes, E.
Right arrow Articles by Klenerman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, E.
Right arrow Articles by Klenerman, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2004, p. 3382-3389, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3382-3389.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic Cells

Eleanor Barnes,1,2 Mariolina Salio,3 Vincenzo Cerundolo,3 Joanne Medlin,4 Shona Murphy,4 Geoffrey Dusheiko,2 and Paul Klenerman1*

Nuffield Department of Medicine,1 Sir William Dunn School of Pathology, University of Oxford,4 Cancer Research UK Tumour Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford,3 Centre for Hepatology, Royal Free Hospital, London, United Kingdom2

Received 12 January 2004/ Returned for modification 29 March 2004/ Accepted 11 May 2004

Alpha interferon and ribavirin are required in combination to achieve a sustained virological response in the treatment of hepatitis C virus (HCV) infection. Alpha interferon has direct antiviral activity and also enhances HCV-specific T-cell responses. Ribavirin has little direct activity against HCV but reduces hepatic inflammation. It is therefore likely that these drugs in combination have hitherto unidentified immunological effects. In the present study we investigated the effects of alpha interferon and ribavirin on dendritic cell (DC) maturation and cytokine production induced by double-stranded RNA in vitro. Alpha interferon alone enhanced the expression of HLA class I, HLA class II, and CD86 on immature DCs but did not stimulate full DC maturation, which requires the expression of CD83. Alpha interferon enhanced the production of interleukin 12 p70 [IL-12(p70)] and tumor necrosis factor alpha (TNF-{alpha}) but had no effect on IL-10 production. In contrast, ribavirin at physiological doses had no effect on DC maturation but markedly suppressed the production of TNF-{alpha}, IL-10, and IL-12(p70). The suppression of cytokines by ribavirin cannot be explained by the induction of DC apoptosis or cell death. Quantitative PCR confirmed that cytokine suppression occurs at the level of mRNA. The suppression of IL-12(p70) and TNF-{alpha} in maturing DCs may explain the reduction in hepatic inflammation observed during ribavirin monotherapy. Combination alpha interferon-ribavirin therapy may alter the cytokine profile of maturing DCs overall by suppressing IL-10 production but maintaining IL-12(p70) and TNF-{alpha} production, a pattern that would favor viral elimination through downstream effects on T cells.

* Corresponding author. Mailing address: Department of Zoology, Peter Medawar Building, South Parks Rd., Oxford OX1 3SY, United Kingdom. Phone: 44 (0)1865 281885. Fax: 44 (0)1865 281236. E-mail: paul.klenerman{at}medawar.ox.ac.uk.

Antimicrobial Agents and Chemotherapy, September 2004, p. 3382-3389, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3382-3389.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cicinnati, V. R., Kang, J., Sotiropoulos, G. C., Hilgard, P., Frilling, A., Broelsch, C. E., Gerken, G., Beckebaum, S. (2008). Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon. J. Gen. Virol. 89: 1243-1253 [Abstract] [Full Text]  
  • Byrnes, A. A., Li, D.-Y., Park, K., Thompson, D., Mocilnikar, C., Mohan, P., Molleston, J. P., Narkewicz, M., Zhou, H., Wolf, S. F., Schwarz, K. B., Karp, C. L. (2007). Modulation of the IL-12/IFN-{gamma} axis by IFN-{alpha} therapy for hepatitis C. J. Leukoc. Biol. 81: 825-834 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»